Status:

RECRUITING

ILUMYA in Combination With HALOG Ointment 0.1% for Plaque Psoriasis.

Lead Sponsor:

Psoriasis Treatment Center of Central New Jersey

Collaborating Sponsors:

Sun Pharmaceutical Industries Limited

Conditions:

Psoriasis

Eligibility:

All Genders

18+ years

Phase:

PHASE4

Brief Summary

Patient with moderate-to-severe plaque psoriasis will receive Ilumya with or without Halog ointment.

Detailed Description

25 adult subjects with moderate to severe plaque psoriasis will receive Ilumya 100mg subcutaneously at weeks 0, 4 and 16. At week 16, patients with remaining BSA ˃3% will be given HALOG ointment 0.1%...

Eligibility Criteria

Inclusion

  • Male or female adult ≥ 18 years of age;
  • Diagnosis of moderate-to-severe chronic plaque-type psoriasis as defined by
  • BSA 10%
  • PGA ≥3
  • PASI ≥12
  • Must be a candidate for phototherapy and/or systemic therapy
  • Females of childbearing potential (FCBP) must have a negative serum pregnancy test at Screening and negative urine pregnancy test at Baseline. FCBP who engage in activity in which conception is possible must use one of the approved contraceptive options: hormonal contraception; intrauterine device (IUD); tubal ligation; or partner's vasectomy; Male or female condom diaphragm with spermicide, cervical cap with spermicide, or contraceptive sponge with spermicide.

Exclusion

  • Non-plaque forms of psoriasis
  • Women of childbearing potential who are pregnant, intend to become pregnant, or are lactating
  • Presence of significant uncontrolled medical condition that in the opinion of the investigator would affect patient safety during the trial.
  • Active or untreated latent tuberculosis (TB)

Key Trial Info

Start Date :

April 6 2020

Trial Type :

INTERVENTIONAL

Allocation :

ESTIMATED

End Date :

March 1 2021

Estimated Enrollment :

25 Patients enrolled

Trial Details

Trial ID

NCT04347473

Start Date

April 6 2020

End Date

March 1 2021

Last Update

April 15 2020

Active Locations (1)

Enter a location and click search to find clinical trials sorted by distance.

Page 1 of 1 (1 locations)

1

Psoriasis Treatment Center of Central New Jersey

East Windsor, New Jersey, United States, 08520